Patent ductus arteriosus
ICD-10 Q25.0 is a billable code used to indicate a diagnosis of patent ductus arteriosus.
Patent ductus arteriosus (PDA) is a congenital heart defect characterized by the persistence of the ductus arteriosus, a blood vessel that connects the pulmonary artery to the aorta during fetal development. Normally, this vessel closes shortly after birth, allowing blood to flow through the lungs for oxygenation. When it remains open (patent), it can lead to abnormal blood flow between the aorta and pulmonary artery, resulting in increased workload on the heart and lungs. Symptoms may include rapid breathing, poor feeding, and failure to thrive in infants. Diagnosis is typically made through echocardiography, which can visualize the ductus and assess the degree of left-to-right shunting. Treatment options include pharmacological closure with nonsteroidal anti-inflammatory drugs (NSAIDs) like indomethacin or surgical intervention in cases where medical management is insufficient. PDA is often associated with other congenital heart defects, such as septal defects and coarctation of the aorta, necessitating comprehensive evaluation and management.
Detailed clinical notes on symptoms, diagnostic imaging results, and treatment plans.
Infants presenting with respiratory distress or failure to thrive due to PDA.
Consideration of gestational age and weight in treatment decisions and coding.
Genetic testing results, family history of congenital heart defects, and any syndromic associations.
Assessment of infants with PDA for potential chromosomal abnormalities like Down syndrome.
Understanding the genetic implications of congenital heart defects and their associations.
Used in cases where medical management fails and surgical intervention is indicated.
Detailed operative report and pre-operative assessment.
Pediatric cardiology documentation standards.
Accurate coding of PDA is crucial for appropriate reimbursement, tracking of congenital heart defects, and ensuring that patients receive the necessary follow-up care. Misclassification can lead to inadequate treatment and poor outcomes.
